To kick off the US Food and Drug Administration’s 17 October town hall at the Medtech Conference in Toronto, Michelle Tarver addressed industry for the first time as acting director of the Center for Devices and Radiological Health (CDRH). Tarver became acting director in July after Jeff Shuren announced he was stepping away from the post, which he has held for 15 years.
Passing The Torch: Tarver Addresses Audience At FDA Town Hall, Recognizes Shuren’s Accomplishments
In her inaugural address to the medtech industry during the Medtech Conference, acting US CDRH director Michelle Tarver described her mission-driven approach.
More from Medtech Insight
More from Policy & Regulation
• By
Stakeholders are pleading for newly confirmed FDA Commissioner Martin Makary to stand up for the agency's high scientific standards and staff as he begins his term.
• By
People living with diabetes who receive continuous glucose monitors (CGMs) through medical supply firms show higher compliance, lower costs of care, and fewer hospitalizations after one year than those who use pharmacies, a new study shows.
• By
Pediatric devices and IVDs are to be a priority. And the European Health Data Space regulation is seen as critical in supporting digital technologies and AI in transforming care.